Form 4 holding
Sr. Vice President of Finance
Silverback Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 37,251
- Estimated value
- $140,921
- Report date
- 02 May 2022
- Price
- $3.78
- Ownership
- Direct
Russ Hawkinson - Sr. Vice President of Finance at ARS Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Sr. Vice President of Finance
- Issuer ticker
- SPRY on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Russ Hawkinson since 10 Sep 2025
Reported holdings for Russ Hawkinson in ARS Pharmaceuticals, Inc.
Form 4 holding
Sr. Vice President of Finance
Silverback Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 56,670
- Estimated value
- Report date
- 02 May 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Russ Hawkinson in ARS Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.